@article{d096b9b25a0c4f96a8c96b5da9c91caf,
title = "ST-elevation acute coronary syndromes in the Platelet Inhibition and Patient Outcomes (PLATO) trial: insights from the ECG substudy",
abstract = "Ticagrelor, when compared with clopidogrel, reduced the 12-month risk of vascular death/myocardial infarction and stroke in patients with ST-elevation acute coronary syndromes intended to undergo primary percutaneous coronary intervention in the PLATelet inhibition and patient Outcomes (PLATO) trial. This prespecified ECG substudy explored whether ticagrelor's association with vascular death and myocardial infarction within 1 year would be amplified by (1) the extent of baseline ST shift and (2) subsequently associated with fewer residual ST changes at hospital discharge.",
keywords = "Acute Coronary Syndrome, Adenosine, Aged, Angioplasty, Balloon, Coronary, Electrocardiography, Female, Humans, Kaplan-Meier Estimate, Male, Middle Aged, Myocardial Infarction, Platelet Aggregation Inhibitors, Purinergic P2Y Receptor Antagonists, Risk Factors, Ticlopidine",
author = "Armstrong, {Paul W} and Hany Siha and Yuling Fu and Westerhout, {Cynthia M} and Steg, {Ph Gabriel} and James, {Stefan K} and Storey, {Robert F} and Jay Horrow and Hugo Katus and Peter Clemmensen and Harrington, {Robert A} and Lars Wallentin",
year = "2012",
doi = "10.1161/CIRCULATIONAHA.111.047530",
language = "English",
volume = "125",
pages = "514--21",
journal = "Circulation (Baltimore)",
issn = "0009-7322",
publisher = "Lippincott Williams and Wilkins",
number = "3",
}